Opinion: Aspirin after a broken bone: health equity in a $5 bottle
There are few things more exciting for researchers than to mount and complete a clinical trial that could change the practice of medicine and save lives. That’s what we experienced when The New England Journal of Medicine published our findings in January 2023 that aspirin was as effective at preventing life-threatening blood clots after surgery as was a far more expensive and more painful injectable blood thinner.
We and our colleagues thought that doctors and hospitals would immediately change their practice and switch to aspirin. This would improve health equity by providing a cheap treatment to people who can’t afford the more expensive one, and would improve quality of life by swapping painful injections for taking two aspirin tablets a day. Unfortunately, change is taking longer than we thought.
Read Original Article: Opinion: Aspirin after a broken bone: health equity in a $5 bottle »
